Bayban’s Privia Health PRVA Stock Holding History

Bayban’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-218	Closed	-$4.48K	–	647
2026 Q1	$4.48K	Sell	218 -863	-80%	-$19.5K	﹤0.01%	480
2025 Q4	$25.6K	Buy	+1,081	New	+$26.3K	0.02%	295

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bayban's PRVA Position: Q2 2026 in Review

Bayban sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 218 shares — an estimated $4.48K sold.

Bayban first reported a position in PRVA in Q4 2025 and held it in 2 quarters. The position peaked at $25.6K in Q4 2025. 281 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

Bayban reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
Bayban sold 218 Privia Health shares in Q2 2026, an estimated $4.48K.
Bayban first reported a position in Privia Health in Q4 2025 and held it in 2 quarters.
Bayban's Privia Health position peaked at $25.6K in Q4 2025.
281 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.